Revenue

With a new strategic investor and a star executive on its board, Apreo Health is poised to advance its breakthrough BREATHE Airway Scaffold for severe emphysema.

As Dye & Durham preps its Q3 earnings call, all eyes are on its transformation plan after a streak of declining revenue and significant net losses.

A $25M payment from partner Chiesi catapults Protalix to a profitable quarter, funding a promising new gout therapy and a broader rare disease strategy.

Tired of flight delays and fragile supply chains? New MIT research reveals how companies can be both hyper-efficient and incredibly resilient.

As Quebecor prepares for its annual meeting, a look at its strong 2025 results, aggressive telecom expansion, and strategy to challenge Canada's giants.

Fourier and Intel reveal how modular, liquid-cooled systems are replacing components to power the next wave of AI, making deployment speed the ultimate weapon.

Intense competition and NHS staff shortages are pushing thousands of qualified British students to pursue medical degrees at international universities.

China's Weichai Power has earned a top global quality award, a first for its industry, signaling a major shift in high-end manufacturing standards.

The new CROSSx Disclosed platform combines Wall Street-style trading relationships with blazing speed, aiming to lower costs and risks for institutions.

Snapsight's new AI tool, Remix, creates branded reports and social campaigns in minutes, turning live sessions into immediate marketing assets.

The German insurer posts a record €4.5B Q1 profit, leveraging AI and strong P&C results to navigate a volatile market and boost shareholder returns.

The uranium giant posts a net profit after its major acquisition, but a significant cash outflow has investors weighing long-term growth against short-term risks.

The nation's largest EMS provider, GMR Solutions, saw its stock surge on its NYSE debut after a major IPO price cut to appease wary investors.

Amid Texas's growing water crisis, a new $3.7M contract for a high-efficiency water treatment plant highlights a critical move toward industrial self-reliance.

HireQuest's persistent $105M cash offer for TrueBlue's on-demand arm puts the staffing giant at a crossroads, fueling speculation of a sector shake-up.

Industrial tech giant Fortive is restructuring its balance sheet, locking in long-term capital to refinance old debt and fund future growth initiatives.

A new study reveals Efsubaglutide Alfa not only controls diabetes but may also improve the body's own insulin-producing cells, heralding a new era.

JBS posts a $221M profit despite a major loss in its US beef unit, showcasing the power of its diversified global strategy in volatile markets.

The Fortune 250 retailer's 10% dividend hike reflects strong financials and a strategic navigation of a complex, evolving automotive landscape.

The utility giant is using a complex forward sale to fund massive infrastructure upgrades, balancing immediate market jitters with long-term strategic growth.